Search Results

You searched for : Dexamethasone  

DATA PUBLISHED IN NEW ENGLAND JOURNAL OF MEDICINE SHOWS PFIZER’S TOFACITINIB MEETS PRIMARY ENDPOINT IN BRAZILIAN STUDY IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA

It is important to note that tofacitinib has not been approved or authorized for use by any regulatory authority worldwide for the treatment of COVID-...
Jun 17

Remdesivir – Antiviral drug for treatment of COVID 19

...
Apr 24

Does Vitamin D offsets Covid-19 infection ? Lancet is all set to investigate

Observational studies already showed the importance of the sunshine vitamin...
Apr 05

Does Vitamin D offsets Covid-19 infection ? Lancet is all set to investigate

Observational studies already showed the importance of the sunshine vitamin...
Apr 05

Rheumatoid arthritis drug reduces risk of death for severely ill hospitalized Covid-19 patients, researchers say

The treatment reduces mortality, shortens hospital stay and reduces the chances of people needing invasive mechanical ventilators...
Feb 12

Janssen received U.S. FDA approval for DARZALEX FASPRO

Genmab announces that Janssen has been Granted U.S. FDA Approval for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) for Patients with Newly Diagnosed Light-chain (...
Jan 16

UK uses Tocilizumab and Sarilumab to treat Covid patients successfully

The new drugs Tocilizumab and Sarilumab are both antiinflammatory medicine and seems to work well to save Covid patient's life...
Jan 12

Antengene announces acceptance of IND application in China

Antengene announces acceptance of IND application in China for ATG-010 (selinexor) in combination with R-GDP (SR-GDP) for the treatment of rrDLBCL in ...
Dec 07

WHO Guideline Development Group advises against use of remdesivir for covid-19

Currently no evidence that it improves survival and other important measures ...
Nov 20

Access to COVID 19 Tools Accelerator commitments reach US$ 5.1billion following new contributions

Donors commit to fund the scale up of the ACT-Accelerator but warn additional funding is critical to support its success ...
Nov 17

BioAegis Therapeutics Expands Phase 2 COVID-19 Treatment Clinical Trial in EU for Inflammation Regulator

BioAegis Therapeutics announced that it has expanded its clinical trial in severe COVID-19 to additional sites in Europe....
Nov 16

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids and shuns ...
Nov 10

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

WHO-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but shunning Gilead's GILD....
Nov 06

Novartis announces collaboration with Molecular Partners to develop two DARPin® therapies designed for potential use against COVID-19

Novartis and Molecular Partners AG today announced a collaboration to develop two DARPin® therapies designed for potential use against COVID-19...
Oct 28

The qualities of Saraswati, Durga, and Laxmi are packed in today’s women, says Dr. Maya Sharma, Global Medical Director, Win Medicare on not limiting oneself and to keep experimenting

...
Oct 27

Steroids boost survival of preterm babies in low-resource settings, new study finds

Accurate pregnancy dating and quality care combined with the steroids are key to survival...
Oct 24

Bristol Myers Squibbs get FDA approval for Opdivo and Yervoy : Malignant Pleural Mesothelioma

Opdivo + Yervoy is the first new systemic therapy in over 15 years to be approved by the FDA ...
Oct 03

Why COVID-19 is Life-Threatening for some

Increasing evidence suggests that some Covid-19 patients get very ill because of an impaired interferon response...
Sep 25

Russia approves 1st COVID-19 prescription drug for sale

Coronavir's approval as a prescription drug follows the green light for another Russian COVID-19 drug, Avifavir, in May...
Sep 19

RECOVERY COVID-19 Phase 3 trial to evaluate Regeneron’s REGN-COV2 starts in UK

COVID-19 Phase 3 Trial to Evaluate Regeneron’s REGN-COV2 Investigational Antibody Cocktail in the UK...
Sep 18

Good immunity is always better then vaccine : Experts

The coronavirus, SARS-CoV-2, is the latest in a procession of new infectious diseases that have surprised the world in recent years...
Sep 15

UK begins trials of new antibody treatment for COVID-19

As part of the government-backed Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trials, monoclonal antibodies...
Sep 15

Senhwa Biosciences reports severe COVID-19 patient recovered in 5 days

The company is encouraged by the patient's strong response to Silmitasertib and will make every effort to provide the drug to critically ill COVID-...
Sep 12

WHO recommends steroid use on critical COVID-19 patients

The WHO's clinical care lead said the agency had updated its advice to include a "strong recommendation" for use of steroids...
Sep 03

Collaboration between Novartis and Africa Medical Supplies : COVID-19 Update

15 generic and over-the-counter (OTC) medicines from Sandoz division will be sold at zero-profit to governments ...
Sep 02

25 Matching result(s) found!

-Advertisements-




Trending Now

Under 15 Children Under Threat: The TB Comeback No One Saw Coming April 04, 2025
MGM Healthcare Performs World's First Modified Multi-Visceral Transplant for Rare Intestinal DisorderApril 04, 2025
World Health Day 2025: St. George’s University’s Role in Preparing Doctors to Tackle Global Health ChallengesApril 04, 2025
Strength Doesn’t Retire: The Science Behind Ageless PowerApril 04, 2025
Beyond the Baby Bump: Can Delayed Pregnancy Increase Autism Risk in ChildrenApril 04, 2025
University of Manchester invites applications for MA Social AnthropologyApril 03, 2025
Ahead of World Health Day, Sova Health Launches Advanced Microbiome Tests & Evidence-Based Precision Supplements April 03, 2025
Half of women cannot make decisions about their reproductive health and bodily autonomyApril 03, 2025
UGRO CAPITAL LIMITED PUBLIC ISSUE OF SECURED, RATED, LISTED, REDEEMABLE, NON-CONVERTIBLE DEBENTURES (SECURED NCDS) OPENS TODAY EFFECTIVE ANNUALIZED YIELD UP TO 11.01% PER ANNUM* April 03, 2025
SF Airlines Entrusts Çelebi India with Freighter Handling at Kempegowda International Airport, BengaluruApril 03, 2025
Is This the Future of Physiotherapy? Inside Stance Health’s $1M ExpansionApril 03, 2025
The Daily Shower Debate: Are You Washing Away Your Skin’s Health?April 03, 2025
The Digital Sleep Thief: How Night-time Screen Addiction is Robbing You of Bed-time RestApril 02, 2025
KKR Launches ‘Knight Bite’ – A Digital Series That Serves Up Food, Fun, and Cricket!April 02, 2025
Crompton rolls out its all new range of Aura, Avancer & Jedi Air Coolers for an effortless summer cooling experienceApril 02, 2025
CARE Hospitals, Hi-Tech City Strengthens Orthopaedics Department with Renowned SurgeonsApril 02, 2025
World Autism Awareness Day: Breaking the Chains of Stigma in IndiaApril 02, 2025
From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025